Physician profile
Mark A Kwartowitz
NPI 1962448803
$3,551.93
in general payments reported to CMS, 2019-2025
26 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $623 · 2020: $1,045 · 2021: $645 · 2022: $306 · 2023: $293 · 2024: $385 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $742.10 | 2019-2022 | |
| Conformis, INC. | $720.11 | 2020-2021 | |
| Stryker Corporation | $368.68 | 2019-2025 | Gamma, Axsos, Alphavent |
| Depuy Synthes Sales INC. | $182.12 | 2019-2025 | Na, Va-Lcp, Speedtrap |
| Abbott Laboratories | $166.05 | 2019-2022 | |
| Pinnacle, INC | $155.16 | 2019-2025 | |
| Pacira Therapeutics, INC. | $154.30 | 2019-2020 | |
| Fidia Pharma USA INC. | $153.99 | 2019-2023 | Hymovis |
| Zimmer Biomet Holdings, INC. | $145.05 | 2021 | |
| Heron Therapeutics, INC. | $129.72 | 2024 | Zynrelef |
| Globus Medical, INC. | $100.99 | 2024 | Distal Femur Plate System |
| Encore Medical, Lp | $87.28 | 2024 | Djo Surgical |
| Smith+Nephew, INC. | $77.55 | 2019-2024 | Spatial Frame, Q-Fix, Healicoil |
| Bioventus LLC | $57.33 | 2019-2025 | Xcell |
| Stimwave Technologies Incorporated | $57.13 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vericel Corporation | $34.76 | 2023 | Maci |
| Linvatec Corporation | $30.41 | 2022 | |
| Biotissue Holdings INC. | $29.36 | 2021 | |
| Nevro Corp. | $27.83 | 2022 | |
| Djo, LLC | $24.71 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $23.93 | 2025 | |
| Orthofix Medical, INC. | $22.40 | 2024 | Physio-Stim |
| Averitas Pharma INC. | $22.27 | 2023 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $14.33 | 2019 | |
| Pfizer INC. | $13.52 | 2019 | |
| Checkpoint Surgical, INC | $10.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kwartowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.